tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
NAUT
Nautilus Biotechnolgy
RESEARCH TOOLSreports

Nautilus Biotechnolgy (NAUT) Income Statement

175 Followers

Nautilus Biotechnolgy Income Statement

Last quarter (Q4 2025), Nautilus Biotechnolgy's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Nautilus Biotechnolgy's net income was $-13.78M. See Nautilus Biotechnolgy’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -6.46M$ -6.35M$ -5.71M$ -3.42M$ -2.84M
Operating Expenses
$ 60.37M$ 75.12M$ 70.45M$ 60.20M$ 47.66M
Depreciation and Amortization
$ 6.46M$ 6.35M$ 1.85M$ 3.42M$ 2.84M
EBITDA
$ -52.54M$ -64.43M$ -74.30M$ -54.51M$ -47.47M
Operating Income
$ -66.84M$ -81.48M$ -76.15M$ -63.62M$ -50.50M
Other Income/Expenses
$ 7.84M$ 10.70M$ 12.48M$ 5.69M$ 183.00K
Pretax Income
$ -59.00M$ -70.78M$ -63.67M$ -57.92M$ -50.31M
Net Income
$ -59.00M$ -70.78M$ -63.67M$ -57.92M$ -50.31M
Per Share Metrics
Basic EPS
$ -0.47$ -0.56$ -0.51$ -0.46$ -0.60
Diluted EPS
$ -0.47$ -0.56$ -0.51$ -0.46$ -0.60
Weighted Average Shares Outstanding
 126.26M 125.43M 124.92M 124.59M 84.46M
Weighted Average Shares Outstanding (Diluted)
 126.26M 125.43M 124.92M 124.59M 84.46M
Currency in USD

Nautilus Biotechnolgy Earnings and Revenue History